BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

460 related articles for article (PubMed ID: 31533774)

  • 1. Long non-coding RNA HOTTIP enhances IL-6 expression to potentiate immune escape of ovarian cancer cells by upregulating the expression of PD-L1 in neutrophils.
    Shang A; Wang W; Gu C; Chen C; Zeng B; Yang Y; Ji P; Sun J; Wu J; Lu W; Sun Z; Li D
    J Exp Clin Cancer Res; 2019 Sep; 38(1):411. PubMed ID: 31533774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic and Clinical Value of Interleukin 6 and CD45
    Wertel I; Suszczyk D; Pawłowska A; Bilska M; Chudzik A; Skiba W; Paduch R; Kotarski J
    J Immunol Res; 2020; 2020():1715064. PubMed ID: 33062717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA HOTTIP promotes the proliferation and invasion of ovarian cancer cells by activating the MEK/ERK pathway.
    Liu J; Hu HB; Liu YM; Li FX; Zhang LP; Liao ZM
    Mol Med Rep; 2020 Nov; 22(5):3667-3676. PubMed ID: 33000231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumour-activated neutrophils in gastric cancer foster immune suppression and disease progression through GM-CSF-PD-L1 pathway.
    Wang TT; Zhao YL; Peng LS; Chen N; Chen W; Lv YP; Mao FY; Zhang JY; Cheng P; Teng YS; Fu XL; Yu PW; Guo G; Luo P; Zhuang Y; Zou QM
    Gut; 2017 Nov; 66(11):1900-1911. PubMed ID: 28274999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The long noncoding RNA HOXA transcript at the distal tip promotes colorectal cancer growth partially via silencing of p21 expression.
    Lian Y; Ding J; Zhang Z; Shi Y; Zhu Y; Li J; Peng P; Wang J; Fan Y; De W; Wang K
    Tumour Biol; 2016 Jun; 37(6):7431-40. PubMed ID: 26678886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. m6A-modified circNFIX promotes ovarian cancer progression and immune escape via activating IL-6R/JAK1/STAT3 signaling by sponging miR-647.
    Wang R; Ye H; Yang B; Ao M; Yu X; Wu Y; Xi M; Hou M
    Int Immunopharmacol; 2023 Nov; 124(Pt A):110879. PubMed ID: 37713785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Programmed death ligand-1 over-expression correlates with malignancy and contributes to immune regulation in ovarian cancer.
    Maine CJ; Aziz NH; Chatterjee J; Hayford C; Brewig N; Whilding L; George AJ; Ghaem-Maghami S
    Cancer Immunol Immunother; 2014 Mar; 63(3):215-24. PubMed ID: 24297569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long noncoding RNA HOTTIP is a significant indicator of ovarian cancer prognosis and enhances cell proliferation and invasion.
    Zou T; Wang PL; Gao Y; Liang WT
    Cancer Biomark; 2019; 25(2):133-139. PubMed ID: 30452402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-6 promotes PD-L1 expression in monocytes and macrophages by decreasing protein tyrosine phosphatase receptor type O expression in human hepatocellular carcinoma.
    Zhang W; Liu Y; Yan Z; Yang H; Sun W; Yao Y; Chen Y; Jiang R
    J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32581055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA HOTTIP promotes papillary thyroid carcinoma cell proliferation, invasion and migration by regulating miR-637.
    Yuan Q; Liu Y; Fan Y; Liu Z; Wang X; Jia M; Geng Z; Zhang J; Lu X
    Int J Biochem Cell Biol; 2018 May; 98():1-9. PubMed ID: 29474928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non‑coding RNA HOTTIP enhances the fibrosis of lung tissues by regulating the miR‑744‑5p/PTBP1 signaling axis.
    Li J; Chai W; Zhao Z; Zhou Y; Wu Q
    Mol Med Rep; 2021 Sep; 24(3):. PubMed ID: 34212978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoblotting Analysis of Intracellular PD-L1 Levels in Interferon-γ-Treated Ovarian Cancer Cells Stably Transfected with Bcl3 shRNA.
    Padmanabhan S; Zou Y; Vancurova I
    Methods Mol Biol; 2020; 2108():211-220. PubMed ID: 31939183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The HOTTIP (HOXA transcript at the distal tip) lncRNA: Review of oncogenic roles in human.
    Ghafouri-Fard S; Dashti S; Taheri M
    Biomed Pharmacother; 2020 Jul; 127():110158. PubMed ID: 32335298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Programmed cell death ligand 1 disruption by clustered regularly interspaced short palindromic repeats/Cas9-genome editing promotes antitumor immunity and suppresses ovarian cancer progression.
    Yahata T; Mizoguchi M; Kimura A; Orimo T; Toujima S; Kuninaka Y; Nosaka M; Ishida Y; Sasaki I; Fukuda-Ohta Y; Hemmi H; Iwahashi N; Noguchi T; Kaisho T; Kondo T; Ino K
    Cancer Sci; 2019 Apr; 110(4):1279-1292. PubMed ID: 30702189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular mechanism of lncRNA SNHG12 in immune escape of non-small cell lung cancer through the HuR/PD-L1/USP8 axis.
    Huang Y; Xia L; Tan X; Zhang J; Zeng W; Tan B; Yu X; Fang W; Yang Z
    Cell Mol Biol Lett; 2022 Jun; 27(1):43. PubMed ID: 35658874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atezolizumab and blockade of LncRNA PVT1 attenuate cisplatin resistant ovarian cancer cells progression synergistically via JAK2/STAT3/PD-L1 pathway.
    Chen Y; Li F; Li D; Liu W; Zhang L
    Clin Immunol; 2021 Jun; 227():108728. PubMed ID: 33878452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. lncRNA EGFR-AS1 facilitates leiomyosarcoma progression and immune escape via the EGFR-MYC-PD-L1 axis.
    Chen ML; Fan L; Huang GR; Sun ZF
    Int Immunol; 2022 Jul; 34(7):365-377. PubMed ID: 35485964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of programmed cell death ligand 1 expression in patients with ovarian carcinoma: A systematic review and meta-analysis.
    Huang LJ; Deng XF; Chang F; Wu XL; Wu Y; Diao QZ
    Medicine (Baltimore); 2018 Oct; 97(43):e12858. PubMed ID: 30412078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA MALAT1 promotes tumorigenesis and immune escape of diffuse large B cell lymphoma by sponging miR-195.
    Wang QM; Lian GY; Song Y; Huang YF; Gong Y
    Life Sci; 2019 Aug; 231():116335. PubMed ID: 30898647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Over-expression of the long non-coding RNA HOTTIP inhibits glioma cell growth by BRE.
    Xu LM; Chen L; Li F; Zhang R; Li ZY; Chen FF; Jiang XD
    J Exp Clin Cancer Res; 2016 Oct; 35(1):162. PubMed ID: 27733185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.